To simultaneously examine adherence to long-term controller and quick-relief medications and to contrast patterns of medication use in children with asthma.
The cornerstone of asthma management in individuals with persistent asthma is the daily use of long-term controller medication for the disease, most notably, inhaled corticosteroids [ 3].
(If not mentioned by the patient, explore the use of a long-term controller medication and the meaning of "long-term") B.2.
The present study complements a similar parallel research endeavor seeking the perspective of physicians regarding barriers and facilitators to prescribing long-term controller medication for asthma [ 25].
The misbelief or lack of a clear diagnosis was reported by patients who, misguided by doubts concerning their diagnosis, refused to take long-term controller medication.
We proposed a taxonomy to support the development of knowledge translation interventions to increase patients' adherence to long-term controller medication for asthma.
We did not specifically record patients' self-report of adherence or objectively documented adherence to long-term controller medication for asthma.
They exhibit lower adherence to medication and only about one-third report using long-term controller medicine or receiving asthma care plans from their clinicians [ 2].
Although asthma morbidity can be prevented through long-term controller medication, most patients with persistent asthma do not take their daily inhaled corticosteroid.
Conversely, a structured follow-up by trained health care professionals enhanced the patients' intention to adhere to long-term controller medication intake because patients were reassured.
Whereas barriers to adherence to long-term controller medication for asthma have been extensively studied in the last decade, the literature on facilitators of adherence to asthma controller medication is scant.
